QIAGEN delivers solid Q4 2024 growth ahead of outlook
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced financial results for the fourth quarter and ...
Qiagen: Q4 Earnings Snapshot
The diagnostic products maker posted revenue of $521.2 million in the period, beating Street forecasts. Seven analysts surveyed by Zacks expected $520.7 million. Qiagen expects full-year earnings to ...
QIAGEN receives positive court decision reaffirming an important QuantiFERON-TB patent
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the German Federal Patent Court ...
Second-tier signings: a busy Deadline Day in the Keuken Kampioen Divisie
Read about all the day’s transfers from the Netherlands’ second division as a number of sides have looked to strengthen their ...